Betrixaban Maleate and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Betrixaban Maleate and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: betrixaban
Brand name: Bevyxxa
Synonyms: Betrixaban
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Betrixaban Maleate-Insulin glargine, recombinant Subcutaneous
- Betrixaban Maleate-Insulin glulisine
- Betrixaban Maleate-Insulin Glulisine (Cartridges and Pens)
- Betrixaban Maleate-Insulin Glulisine (Vials)
- Betrixaban Maleate-Insulin glulisine Subcutaneous
- Betrixaban Maleate-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Bevacizumab
- Insulin glargine and lixisenatide Subcutaneous-Bevacizumab Injection
- Insulin glargine and lixisenatide Subcutaneous-Bevacizumab Intravenous
- Insulin glargine and lixisenatide Subcutaneous-Bevacizumab-awwb
- Insulin glargine and lixisenatide Subcutaneous-Bevacizumab-awwb Intravenous
- Insulin glargine and lixisenatide Subcutaneous-Bevespi Aerosphere